|
End-of-day quote
New Zealand S.E.
2026-08-21
|
5-day change | 1st Jan Change | ||
| 7.000 NZD | +2.49% |
|
0.00% | -5.41% |
| 08-13 | NZX Biggest Gainers | MT |
| 05-17 | AFT Pharmaceuticals Appoints CFO | MT |
Company Valuation: Sanford Limited
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 476.9 | 390.9 | 363.7 | 352.5 | 517.1 | 654.5 | - | - |
| Change | - | -18.04% | -6.94% | -3.08% | 46.68% | 26.58% | - | - |
| Enterprise Value (EV) 1 | 655.5 | 536.3 | 559.9 | 538 | 570.5 | 736.3 | 687.1 | 639.9 |
| Change | - | -18.18% | 4.4% | -3.91% | 6.03% | 29.06% | -6.68% | -6.87% |
| P/E | 29.3x | 6.99x | 36.4x | 17.9x | 8.12x | 10x | 10.3x | 9.48x |
| PBR | 0.75x | - | 0.53x | 0.5x | 0.7x | 0.83x | 0.78x | 0.74x |
| PEG | - | 0x | -0.4x | 0.2x | 0x | 3.71x | -3.64x | 1.1x |
| Capitalization / Revenue | 0.97x | 0.73x | 0.66x | 0.6x | 0.89x | 1.17x | 1.12x | 1.09x |
| EV / Revenue | 1.34x | 1.01x | 1.01x | 0.92x | 0.98x | 1.31x | 1.18x | 1.06x |
| EV / EBITDA | 12.5x | 7.86x | 6.87x | 4.95x | 4.05x | 5.25x | 5.14x | 4.61x |
| EV / EBIT | 28.1x | 13.3x | 11.3x | 7.25x | 5.42x | 7.4x | 7.33x | 6.46x |
| EV / FCF | - | - | - | - | 5.06x | 15.1x | 12.6x | 9.67x |
| FCF Yield | - | - | - | - | 19.8% | 6.6% | 7.95% | 10.3% |
| Dividend per Share 2 | - | 0.1 | 0.12 | 0.1 | 0.1 | 0.1 | 0.1375 | 0.2825 |
| Rate of return | - | 2.39% | 3.08% | 2.65% | 1.81% | 1.43% | 1.96% | 4.04% |
| EPS 2 | 0.174 | 0.598 | 0.107 | 0.211 | 0.681 | 0.6993 | 0.6796 | 0.7383 |
| Distribution rate | - | 16.7% | 112% | 47.4% | 14.7% | 14.3% | 20.2% | 38.3% |
| Net sales 1 | 489.6 | 531.9 | 553.4 | 582.9 | 584.1 | 561.3 | 584.1 | 602.4 |
| EBITDA 1 | 52.6 | 68.26 | 81.53 | 108.6 | 141 | 140.1 | 133.6 | 138.8 |
| EBIT 1 | 23.29 | 40.18 | 49.39 | 74.21 | 105.2 | 99.55 | 93.79 | 98.99 |
| Net income 1 | 16.26 | 55.89 | 10.02 | 19.68 | 63.69 | 65.43 | 63.58 | 69.08 |
| Net Debt 1 | 178.6 | 145.5 | 196.2 | 185.5 | 53.41 | 81.74 | 32.57 | -14.63 |
| Reference price 2 | 5.100 | 4.180 | 3.890 | 3.770 | 5.530 | 7.000 | 7.000 | 7.000 |
| Nbr of stocks (in thousands) | 93,506 | 93,506 | 93,506 | 93,506 | 93,506 | 93,506 | - | - |
| Announcement Date | 11/17/21 | 11/14/22 | 11/13/23 | 11/15/24 | 11/17/25 | - | - | - |
1NZD in Million2NZD
Estimates
P/E, Detailed evolution
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SAN Stock
- Valuation Sanford Limited
Select your edition
All financial news and data tailored to specific country editions
